Intrauterine growth restriction modifies the normal gene expression in kidney from rabbit fetuses

Early Human Development

Volumn 88, Issue 11, 2012, Pages 899-904

  Figueroa, Horacio ^a,b   Lozano, Mauricio ^a   Suazo, Cristian ^a   Eixarch, Elisenda ^c,d,e   Illanes, Sebastian E ^a,b   Carreño, Juan Eduardo ^a   Villanueva, Sandra ^a   Hernández Andrade, Edgar ^c,d,e,f   Gratacós, Eduard ^c,d,e   Irarrazabal, Carlos E ^a  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b Section of Gastroenterology   (Chile)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^f National Institute of Perinatal Medicine   (Mexico)

Author keywords

Hypoxia; Inflammation; IUGR; Osmotic stress; Rabbit

Indexed keywords

ATM PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NFAT5 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL RABBIT; FEMALE; FETUS; FETUS BLOOD; FETUS DEVELOPMENT; GENE EXPRESSION; GLOMERULUS; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; KIDNEY; KIDNEY DEVELOPMENT; KIDNEY INJURY; KIDNEY SIZE; NONHUMAN; OSMOTIC STRESS; PLACENTA CIRCULATION; PRENATAL GROWTH; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; FETAL GROWTH RETARDATION; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, ESSENTIAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-1BETA; KIDNEY; LIPOCALINS; NFATC TRANSCRIPTION FACTORS; PLACENTA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RABBITS; TUMOR SUPPRESSOR PROTEINS;

EID: 84866851709     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.07.010     Document Type: Article

References (43)

1. Soothill P.W., Bobrow C.S., Holmes R. Small for gestational age is not a diagnosis. Ultrasound Obstet Gynecol 1999, 13(4):225-228.
2. Bernstein I.M., Horbar J.D., Badger G.J., Ohlsson A., Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000, 182(1 Pt 1):198-206.
3. Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol 2003, 110(Suppl. 1):S99-S107.
4. Marsal K. Intrauterine growth restriction. Curr Opin Obstet Gynecol 2002, 14(2):127-135.
5. Pardi G., Marconi A.M., Cetin I. Placental-fetal interrelationship in IUGR fetuses-a review. Placenta 2002, 23(Suppl. A):S136-S141.
6. Ferrazzi E., Bozzo M., Rigano S., Bellotti M., Morabito A., Pardi G., et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002, 19(2):140-146.
7. De Prins F.A., Van Assche F.A. Intrauterine growth retardation and development of endocrine pancreas in the experimental rat. Biol Neonate 1982, 41(1-2):16-21.
8. Fall C.H., Stein C.E., Kumaran K., Cox V., Osmond C., Barker D.J., et al. Size at birth, maternal weight, and type 2 diabetes in South India. Diabet Med 1998, 15(3):220-227.
9. Barker D.J., Martyn C.N., Osmond C., Hales C.N., Fall C.H. Growth in utero and serum cholesterol concentrations in adult life. BMJ 1993, 307(6918):1524-1527.
10. Martyn C.N., Lever A.F., Morton J.J. Plasma concentrations of inactive renin in adult life are related to indicators of foetal growth. J Hypertens 1996, 14(7):881-886.
11. Barker D.J., Eriksson J.G., Forsen T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002, 31(6):1235-1239.
12. Buffat C., Boubred F., Mondon F., Chelbi S.T., Feuerstein J.M., Lelievre-Pegorier M., et al. Kidney gene expression analysis in a rat model of intrauterine growth restriction reveals massive alterations of coagulation genes. Endocrinology 2007, 148(11):5549-5557.
13. Irarrazabal C.E., Liu J.C., Burg M.B., Ferraris J.D. ATM, a DNA damage-inducible kinase, contributes to activation by high NaCl of the transcription factor TonEBP/OREBP. Proc Natl Acad Sci U S A 2004, 101(23):8809-8814.
14. Villanuevan S., Suazo C., Santapau D., Perez F. QuirozM, Careño JE, Illanes S, Lavandero S, Michea L, and Irarrazabal CE (2012) NFAT5 is activated by hypoxia: role in ischemia and reperfusion in the rat kidney. PLoS One 2012, 7(7):e39665.
15. Lopez-Rodriguez C., Antos C.L., Shelton J.M., Richardson J.A., Lin F., Novobrantseva T.I., et al. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci U S A 2004, 101(8):2392-2397.
16. Lam A.K., Ko B.C., Tam S., Morris R., Yang J.Y., Chung S.K., et al. Osmotic response element-binding protein (OREBP) is an essential regulator of the urine concentrating mechanism. J Biol Chem 2004, 279(46):48,048-48,054.
17. Gunaratnam L., Bonventre J.V. HIF in kidney disease and development. J Am Soc Nephrol 2009, 20(9):1877-1887.
18. Gwira J.A., Wei F., Ishibe S., Ueland J.M., Barasch J., Cantley L.G. Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 2005, 280(9):7875-7882.
19. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14(10):2534-2543.
20. Mishra J., Mori K., Ma Q., Kelly C., Yang J., Mitsnefes M., et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004, 15(12):3073-3082.
21. Arena A., Stassi G., Iannello D., Gazzara D., Calapai M., Bisignano C., et al. Both IL-1beta and TNF-alpha regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients. Mediators Inflamm 2010, 2010:613937.
22. Viau A., El K.K., Laouari D., Burtin M., Nguyen C., Mori K., et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010, 120(11):4065-4076.
23. Guerra M.S., Roncon-Albuquerque R., Lourenco A.P., Falcao-Pires I., Cibrao-Coutinho P., Leite-Moreira A.F. Remote myocardium gene expression after 30 and 120min of ischaemia in the rat. Exp Physiol 2006, 91(2):473-480.
24. Irarrazabal C.E., Gallazzini M., Schnetz M.P., Kunin M., Simons B.L., Williams C.K., et al. Phospholipase C-gamma1 is involved in signaling the activation by high NaCl of the osmoprotective transcription factor TonEBP/OREBP. Proc Natl Acad Sci U S A 2010, 107(2):906-911.
25. Atzori L., Mussap M., Noto A., Barberini L., Puddu M., Coni E., et al. Clinical metabolomics and urinary NGAL for the early prediction of chronic kidney disease in healthy adults born ELBW. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):40-43.
26. Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010, 15(4):419-428.
27. Eixarch E., Figueras F., Hernandez-Andrade E., Crispi F., Nadal A., Torre I., et al. An experimental model of fetal growth restriction based on selective ligature of uteroplacental vessels in the pregnant rabbit. Fetal Diagn Ther 2009, 26(4):203-211.
28. Gilbert T., Gaonach S., Moreau E., Merlet-Benichou C. Defect of nephrogenesis induced by gentamicin in rat metanephric organ culture. Lab Invest 1994, 70(5):656-666.
29. Amri K., Freund N., Vilar J., Merlet-Benichou C., Lelievre-Pegorier M. Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies. Diabetes 1999, 48(11):2240-2245.
30. Hammond E.M., Giaccia A.J. The role of ATM and ATR in the cellular response to hypoxia and re-oxygenation. DNA Repair (Amst) 2004, 3(8-9):1117-1122.
31. Eixarch E., Hernandez-Andrade E., Crispi F., Illa M., Torre I., Figueras F., et al. Impact on fetal mortality and cardiovascular Doppler of selective ligature of uteroplacental vessels compared with undernutrition in a rabbit model of intrauterine growth restriction. Placenta 2011, 32(4):304-309.
32. Bassan H., Trejo L.L., Kariv N., Bassan M., Berger E., Fattal A., et al. Experimental intrauterine growth retardation alters renal development. Pediatr Nephrol 2000, 15(3-4):192-195.
33. Martin C.B. Normal fetal physiology and behavior, and adaptive responses with hypoxemia. Semin Perinatol 2008, 32(4):239-242.
34. Bencokova Z., Kaufmann M.R., Pires I.M., Lecane P.S., Giaccia A.J., Hammond E.M. ATM activation and signaling under hypoxic conditions. Mol Cell Biol 2009, 29(2):526-537.
35. Sykes E., Cosgrove J.F. Acute renal failure and the critically ill surgical patient. Ann R Coll Surg Engl 2007, 89(1):22-29.
36. Miyakawa H., Woo S.K., Dahl S.C., Handler J.S., Kwon H.M. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci U S A 1999, 96(5):2538-2542.
37. Woo S.K., Nahm O., Kwon H.M. How salt regulates genes: function of a Rel-like transcription factor TonEBP. Biochem Biophys Res Commun 2000, 278(2):269-271.
38. D'Anna R., Baviera G., Giordano D., Russo S., Dugo N., Santamaria A., et al. First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. Prenat Diagn 2009, 29(11):1066-1068.
39. D'Anna R., Baviera G., Giordano D., Todarello G., Russo S., Recupero S., et al. Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 2010, 89(2):275-278.
40. Mao S., Jiang T., Shang G., Wu Z., Zhang N. Increased expression of neutrophil gelatinase-associated lipocalin receptor by interleukin-1beta in human mesangial cells via MAPK/ERK activation. Int J Mol Med 2011, 27(4):555-560.
41. Qian D., Lin H.Y., Wang H.M., Zhang X., Liu D.L., Li Q.L., et al. Normoxic induction of the hypoxic-inducible factor-1 alpha by interleukin-1 beta involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells. Biol Reprod 2004, 70(6):1822-1827.
42. Brameld J.M., Buttery P.J., Dawson J.M., Harper J.M. Nutritional and hormonal control of skeletal-muscle cell growth and differentiation. Proc Nutr Soc 1998, 57(2):207-217.
43. Langley-Evans S.C. Nutritional programming of disease: unravelling the mechanism. J Anat 2009, 215(1):36-51.